Skip to content
Use case 149

Vaccine Cold-Storage Controllers

A deployment concept for health departments, pharmacies, clinics, hospitals and cold-chain vendors.

Proposed deployment · Compatibility assessment required
Healthcare and Life Sciences

Why this environment matters

The trust boundary for vaccine cold-storage controllers matters because the system monitors and controls refrigerators or freezers that preserve temperature-sensitive vaccines. The operational threat is specific: disabled alarms or falsified temperature records can allow ineffective stock to remain in use. A NØNOS-based design could reduce ambient authority and make the system easier to reset, inspect and attest.

The security challenge

Healthcare systems process deeply sensitive data while supporting time-critical clinical decisions. Security must improve trust without delaying care or obscuring the human responsibility for treatment. In vaccine cold-storage controllers, the decisive risk is that disabled alarms or falsified temperature records can allow ineffective stock to remain in use. Even strong perimeter controls may not help once authorised software, a vendor tool or a valid user session has been compromised. Internal permission boundaries must remain enforceable after initial access.

How the capsule model could help

For this system, NØNOS could isolate temperature sensing, compressor control, alarm delivery and audit export, signing calibration and firmware changes. The design would combine isolated medical file parsers, minimal sensitive persistence, attested privileged sessions and patient-context capabilities. The intended result would be a set of small trust boundaries instead of one large operating environment where every service inherits broad ambient access.

Separate address spaces and capability checks can limit cross-process reach. They cannot stop harmful use of legitimate permissions, prove AI decisions correct or substitute for domain-specific safety controls.

Deployment requirements

Clinical deployment would require medical-device validation, patient-safety risk management, privacy review, human factors testing and integration with existing approved workflows. Security controls must never obstruct emergency care.

Current public-beta limitations, hardware support and application availability must be assessed before any pilot. Neither this use case nor an industry source establishes NONOS certification or a current customer deployment.

Who could buy or integrate it?

  • Biomedical refrigeration manufacturers integrating control electronics
  • Vaccine storage operators purchasing monitored cold-storage equipment
  • Cold-chain systems integrators installing storage monitoring gateways

Industry examples: Haier Biomedical, Thermo Fisher Scientific. Organisations shown illustrate the industry. No NONOS customer, partner or endorsement relationship is implied.

Market opportunity

Market benchmarks and device scenarios.

Published industry benchmark
US$4.6 billion

Biomedical refrigerators and freezers

Global · 2025 · annual market estimate

Biomedical refrigeration and freezing equipment for blood, samples, medicines and vaccines.

Modelled global devices
100K–2M

Candidate OS endpoints

Hypothetical planning range · 2025

Low confidence: planning assumptions. Hardware compatibility, procurement and adoption have not been validated.

Illustrative annual licensing
$500K–$100M

USD / year at full model coverage

Device scenario × assumed US$5–$50 per device / year.

Not a revenue forecast, announced price or measured serviceable market.

Device calculation

Hypothetical global planning range, 2025 scenario: assume 100,000–500,000 vaccine depots and immunization clinics with controlled cold storage × 1–4 candidate OS endpoints per site/asset = 100,000–2,000,000 endpoints. Counting unit: cold-storage supervisory controllers; passive temperature loggers excluded. Site and asset counts, and devices per site, are planning assumptions. The installed base has not been measured. Coverage is limited to the defined equipped subset; includes all candidate endpoints within that assumed subset. Hardware eligibility, certification, adoption and achievable NØNOS share are unverified; overlaps other cases.

Biomedical Refrigerators And Freezers Market Report ↗

Market context only; separate from device and site population estimates. Original monetary-market scope and geography are preserved in benchmark. This source does not establish the assumed worldwide site count or endpoint density.

How to interpret the figures

Adjacent or broader commercial market benchmark; not the NØNOS OS market, licensable-device count or revenue forecast.

Modelled candidate endpoints multiplied by an assumed annual USD price per endpoint. Pricing is a planning assumption, not a vendor quote. This illustrates the full scenario range, not revenue or total addressable market. It excludes adoption timing, procurement, certification, support costs, channel economics and achievable market share. Use cases can overlap, so their totals do not represent unique devices.

Research from 2026. Publisher estimates have not been independently audited.

Read the full methodology

Explore NONOS

Choose your
NONOS experience.

Discover the platform for your organisation or explore the software.

You can reopen this chooser from the footer at any time.